Infliximab and adalimumab, unlike ustekinumab, increase serum KL-6 levels in Japanese patients with psoriasis

被引：9
作者：
Yanaba, Koichi [1 ]
Umezawa, Yoshinori [1 ]
Sakakihara, Reiko [1 ]
Chiba, Miki [1 ]
Ito, Toshihiro [1 ]
Kikuchi, Sota [1 ]
Fukuchi, Osamu [1 ]
Asahina, Akihiko [1 ]
Saeki, Hidehisa [2 ]
Nakagawa, Hidemi [1 ]
机构：
[1] Jikei Univ, Sch Med, Dept Dermatol, Tokyo 1058461, Japan
[2] Nippon Med Sch, Dept Dermatol, Tokyo 113, Japan
来源：
JOURNAL OF DERMATOLOGY | 2015年 / 42卷 / 08期
关键词：
AD HOC COMMITTEE; RHEUMATOID-ARTHRITIS; BIOLOGICAL DMARDS; ELEVATION; COLLEGE; DISEASE; SAFETY;
D O I：
10.1111/1346-8138.12918
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：828 / 829
页数：2
相关论文
共 33 条
  • [1] Elevation of serum KL-6 levels during treatment with tumor necrosis factor-α inhibitor in patients with psoriasis
    Mabuchi, Tomotaka
    Yamaoka, Hanako
    Kawai, Mayu
    Ota, Tami
    Ozawa, Akira
    JOURNAL OF DERMATOLOGY, 2014, 41 (12) : 1136 - 1137
  • [2] Change in Serum KL-6 Level during Biologic Treatment for Psoriasis
    Hoashi, Toshihiko
    Miyazaki, Shun
    Ozaki, Saeko
    Ichiyama, Susumu
    Ito, Michiko
    Kanda, Naoko
    Saeki, Hidehisa
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2023, 90 (02) : 194 - 201
  • [3] Elevation of serum KL-6 levels in 3 patients with rheumatoid arthritis treated with adalimumab
    Koiwa, Masahito
    Goto, Susumu
    Takenouchi, Kenji
    Takahasi, Kenji
    Kamada, Toshikazu
    Nakamura, Hiroshi
    MODERN RHEUMATOLOGY, 2012, 22 (01) : 147 - 151
  • [4] AdalimumabElevation of serum KL-6 levels: 3 case reports
    Reactions Weekly, 2012, 1413 (1) : 6 - 6
  • [5] Different MUC1 gene polymorphisms in German and Japanese ethnicities affect serum KL-6 levels
    Horimasu, Yasushi
    Hattori, Noboru
    Ishikawa, Nobuhisa
    Kawase, Shigeo
    Tanaka, Sonosuke
    Yoshioka, Koji
    Yokoyama, Akihito
    Kohno, Nobuoki
    Bonella, Francesco
    Guzman, Josune
    Ohshimo, Shinichiro
    Costabel, Ulrich
    RESPIRATORY MEDICINE, 2012, 106 (12) : 1756 - 1764
  • [6] Serum KL-6 levels predict clinical outcomes and are associated with MUC1 polymorphism in Japanese patients with COVID-19
    Azekawa, Shuhei
    Chubachi, Shotaro
    Asakura, Takanori
    Namkoong, Ho
    Sato, Yasunori
    Edahiro, Ryuya
    Lee, Ho
    Tanaka, Hiromu
    Otake, Shiro
    Nakagawara, Kensuke
    Fukushima, Takahiro
    Watase, Mayuko
    Sakurai, Kaori
    Kusumoto, Tatsuya
    Masaki, Katsunori
    Kamata, Hirofumi
    Ishii, Makoto
    Hasegawa, Naoki
    Okada, Yukinori
    Koike, Ryuji
    Kitagawa, Yuko
    Kimura, Akinori
    Imoto, Seiya
    Miyano, Satoru
    Ogawa, Seishi
    Kanai, Takanori
    Fukunaga, Koichi
    BMJ OPEN RESPIRATORY RESEARCH, 2023, 10 (01)
  • [7] Elevation of serum KL-6 in patients with psoriasis treated with anti-tumour necrosis factor- therapy
    Higashi, Y.
    Tada, K.
    Shimokawa, M.
    Kawai, K.
    Kanekura, T.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2016, 41 (01) : 88 - 90
  • [8] Serum KL-6 Elevation and Possible Pulmonary Involvement in Patients with Rheumatoid Arthritis Treated with Biological Agents
    Takahashi, Kenji
    Nakamura, Hiroshi
    Takenouchi, Kenji
    Iizawa, Norishige
    Koiwa, Masahito
    Sato, Akiko
    Mochizuki, Yusuke
    Watanabe, Hiroshi
    Takai, Shinro
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2014, 81 (06) : 364 - 371
  • [9] Impact of anti-tumor necrosis factor- agents on serum levels of KL-6 and surfactant protein-D in patients with psoriasis
    Hayashi, Mitsuha
    Yanaba, Koichi
    Umezawa, Yoshinori
    Asahina, Akihiko
    Nakagawa, Hidemi
    JOURNAL OF DERMATOLOGY, 2017, 44 (09) : 1063 - 1066
  • [10] Serum KL-6 Levels as a Biomarker of Lung Injury in Respiratory Syncytial Virus Bronchiolitis
    Kawasaki, Yukihiko
    Aoyagi, Yoshimichi
    Abe, Yusaku
    Go, Hayato
    Imamura, Takashi
    Kaneko, Mari
    Ito, Masaki
    Katayose, Masahiko
    Hashimoto, Koichi
    Hosoya, Mitsuaki
    JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (12) : 2104 - 2108
1234